Anavex Life Sciences Corp (AVXL)

[Chemdeps]

I just finished listening to the CC and I agree. I was surprised by the additional detail that was provided indicating that after seeing the Alzheimers data the EMA requested that Anavex submit an application "immediately" and that Anavex was pulled into it (the submittal) as opposed to pushing the application with EMA. I also liked hearing that the cash runway of 4 years does not include the costs associated with marketing/commercialization of A-273 should the EMA offer approval. Rett feedback continues to be strong from the open label extension as well as support for P3 trial and Schizophrenia trial is moving very fast. The next six months should be interesting....